Cybrexa

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.

Cytovation

This company develops synthetic peptide immunotherapies to treat patients with solid tumours by targeting cancer cell membranes and stimulating immune responses.

Kivu Bioscience

Kivu Bioscience develops next-generation antibody-drug conjugates to provide oncology treatments for cancer patients while reducing off-target side effects.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.